What happens to GW Pharma stock?
Jazz Pharmaceuticals (NASDAQ:JAZZ) has officially closed its $7.2B acquisition of GW Pharmaceuticals plc (NASDAQ:GWPH). GW shareholders gave the thumbs up to the deal last month. With the acquisition, Jazz gains access to GW’s cannabinoid portfolio, including Epidiolex, which raked in $510.5M in sales in 2020.
Is GW Pharmaceuticals a good investment?
That resiliency combined with the company’s growth prospects make it a terrific investment to hang on to for years and years. And the recent drop in price only makes GW Pharmaceuticals stock an even better buy overall.
What’s the stock price on GW Pharmaceuticals?
Key Turning Points
Who bought GW Pharmaceuticals?
A big merger at the intersection of the marijuana and pharmaceutical industries is one step closer to completion. On Friday, shareholders of GW Pharmaceuticals (GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (JAZZ 2.58%), both companies announced in a joint press release.
Should I sell my GW Pharmaceuticals stock?
GW Pharmaceuticals PLC(GWPH-Q) Rating A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
Does GW Pharmaceuticals still exist?
In May 2013, the company became dual-listed on the NASDAQ and AIM. In 2014, the company made a deal with New York to develop clinical trials using cannabidiol (CBD) to treat children who suffer from seizures and other medical complications. In May 2021, Jazz Pharmaceuticals acquired the company.
Should I sell GW Pharmaceuticals stock?
Why is GWPH stock dropping?
Shares of GW Pharmaceuticals PLC gwph slumped 12% Friday, after the company swung to a loss in the second quarter, hurt by the effect of the coronavirus pandemic.
What is the ticker symbol for GW Pharmaceuticals?
GW Pharmaceuticals trades on the NASDAQ under the ticker symbol “GWPH.”
Has GW Pharmaceuticals been sold?
DUBLIN , May 5, 2021 /PRNewswire/ — Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.
Is Jazz Pharmaceuticals an acquisition target?
Corinne Cardina: Another deal that was more recently announced just this week, Jazz Pharmaceuticals announced that they were going to be acquiring GW Pharmaceuticals. That is the British company that has the only FDA-approved CBD derived drug, Epidiolex. Jazz may be a new name for pot investors.
Is GW Pharmaceuticals publicly traded?
GW Pharmaceuticals shares (GWPH) are listed on the NASDAQ and all prices are listed in US Dollars. GW Pharmaceuticals employs 1,161 staff and has a trailing 12-month revenue of around 0.00.